LOGIN
AAOS 2015: Tobramycin bone cement and intravenous tobramycin in TKA
April 2015
AAOS 2015: Tobramycin bone cement and intravenous tobramycin in TKA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Low dose tobramycin bone cement in total knee arthroplasty: an in vivo elution analysis and comparison
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
15 patients scheduled for primary total knee arthroplasty were randomized to either tobramycin-laden bone cement or intravenous administration of tobramycin. The purpose of this study was to measure intra-articular and serum concentrations of tobramycin associated with either administration method. Tobramycin concentrations were measured at 6, 24, and 48 hours after surgery. Administration through...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.